they do not predict how a given medication will perform
June 4, 2024 | Global Equity It seems like everyone is talking about Ozempic, but this popular weight loss drug is only one of many glucagon-like peptide-1 (GLP-1) medications establishing themselves as the cornerstone in the management of obesity
In a 4-week pilot trial, verbal fluency scores increased in the group treated with intranasal insulin and scores decreased in the placebo group, but there were no significant paired comparisons identified, reflecting the limited sample size
Future research should prioritize elucidating the molecular mechanisms behind the antitumor effects, refining individualized treatment strategies, investigating early tumor prevention applications, assessing potential benefits for non-diabetic populations, advancing the development of novel therapies, establishing robust safety monitoring frameworks, and building precision medicine decision-making platforms
If you suspect hormones may be playing a role, speak to your doctor for appropriate tests and management options
Will insurance cover meds